相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer
Ameet A. Chimote et al.
CANCER RESEARCH (2017)
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Bruce N. Cronstein et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Targeting A2 adenosine receptors in cancer
David Allard et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
Si-Rui Ma et al.
MOLECULAR CANCER (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes
Astrid De Meulenaere et al.
PATHOLOGY (2017)
Novel Elements of Immune Suppression within the Tumor Microenvironment
Devikala Gurusamy et al.
CANCER IMMUNOLOGY RESEARCH (2017)
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Martin Turcotte et al.
CANCER RESEARCH (2017)
Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma
Juan Fang et al.
BMC CANCER (2017)
CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
Bruno G. Leclerc et al.
CLINICAL CANCER RESEARCH (2016)
Nanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype
Ameet A. Chimote et al.
JOURNAL OF AUTOIMMUNITY (2016)
Ionic immune suppression within the tumour microenvironment limits T cell effector function
Robert Eil et al.
NATURE (2016)
Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities
Luca Antonioli et al.
TRENDS IN CANCER (2016)
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
Martin Turcotte et al.
CANCER RESEARCH (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses
Paul A. Beavis et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Targeting the Small- and Intermediate-Conductance Ca2+-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin Interface
Meng Cui et al.
NEUROSIGNALS (2014)
Targeting Cancer-Derived Adenosine: New Therapeutic Approaches
Arabella Young et al.
CANCER DISCOVERY (2014)
Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
Michail V. Sitkovsky et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer
Panagiotis Balermpas et al.
ONCOIMMUNOLOGY (2014)
New Positive Ca2+-Activated K+ Channel Gating Modulators with Selectivity for KCa3.1
Nichole Coleman et al.
MOLECULAR PHARMACOLOGY (2014)
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
Bertrand Allard et al.
CLINICAL CANCER RESEARCH (2013)
Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma
Sebastien Albert et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2013)
Selective Inhibition of KCa3.1 Channels Mediates Adenosine Regulation of the Motility of Human T Cells
Ameet A. Chimote et al.
JOURNAL OF IMMUNOLOGY (2013)
Blockade of Kv1.3 Potassium Channels Inhibits Differentiation and Granzyme B Secretion of Human CD8+T Effector Memory Lymphocytes
Lina Hu et al.
PLOS ONE (2013)
CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Gene-engineered T cells for cancer therapy
Michael H. Kershaw et al.
NATURE REVIEWS CANCER (2013)
CD73-Deficient Mice Are Resistant to Carcinogenesis
John Stagg et al.
CANCER RESEARCH (2012)
Disruption of Kv1.3 Channel Forward Vesicular Trafficking by Hypoxia in Human T Lymphocytes
Ameet A. Chimote et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Chemokine-dependent T cell migration requires aquaporin-3-mediated hydrogen peroxide uptake
Mariko Hara-Chikuma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
KCa3.1 and TRPM7 Channels at the Uropod Regulate Migration of Activated Human T Cells
Zerrin Kuras et al.
PLOS ONE (2012)
CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4+ T effector cells in patients with head and neck squamous cell carcinoma
Magis Mandapathil et al.
ONCOIMMUNOLOGY (2012)
Ion channels and transporters in lymphocyte function and immunity
Stefan Feske et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
μ-Slide Chemotaxis: A new chamber for long-term chemotaxis studies
Pamela Zengel et al.
BMC CELL BIOLOGY (2011)
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
Sebastian F. M. Haeusler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
John Stagg et al.
CANCER RESEARCH (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Adenosine and Prostaglandin E2 Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The functional network of ion channels in T lymphocytes
Michael D. Cahalan et al.
IMMUNOLOGICAL REVIEWS (2009)
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function
Balazs Csoka et al.
FASEB JOURNAL (2008)
Regulatory T cells: What role do they play in antitumor immunity in patients with head and neck cancer?
Osama Alhamarneh et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)
A2A adenosine receptor protects tumors from antitumor T cells
Akio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Signalling during hypoxia in human T lymphocytes -: critical role of the src protein tyrosine kinase p56Lck in the O2 sensitivity of Kv1.3 channels
Peter Szigligeti et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Hypoxia modulates early events in T cell receptor-mediated activation in human T lymphocytes via Kv1.3 channels
JR Robbins et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A(2A) receptors
MV Sitkovsky et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: A possible role in T cell proliferation
L Conforti et al.
JOURNAL OF IMMUNOLOGY (2003)
Up-regulation of the IKCa1 potassium channel during T-cell activation -: Molecular mechanism and functional consequences
S Ghanshani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1:: A potential immunosuppressant
H Wulff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
